nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydromorphone—PTGS1—esophageal cancer	0.713	1	CbGaD
Hydromorphone—Naloxone—TLR4—esophageal cancer	0.00303	0.681	CrCbGaD
Hydromorphone—Polyuria—Capecitabine—esophageal cancer	0.000587	0.00352	CcSEcCtD
Hydromorphone—Swelling—Capecitabine—esophageal cancer	0.000584	0.0035	CcSEcCtD
Hydromorphone—Gastroenteritis—Capecitabine—esophageal cancer	0.000581	0.00349	CcSEcCtD
Hydromorphone—Oliguria—Methotrexate—esophageal cancer	0.000573	0.00344	CcSEcCtD
Hydromorphone—Hyperuricaemia—Methotrexate—esophageal cancer	0.00057	0.00342	CcSEcCtD
Hydromorphone—Hepatic enzyme increased—Methotrexate—esophageal cancer	0.000559	0.00335	CcSEcCtD
Hydromorphone—Dysarthria—Methotrexate—esophageal cancer	0.000559	0.00335	CcSEcCtD
Hydromorphone—Libido decreased—Capecitabine—esophageal cancer	0.000556	0.00333	CcSEcCtD
Hydromorphone—Increased appetite—Capecitabine—esophageal cancer	0.000548	0.00329	CcSEcCtD
Hydromorphone—Amnesia—Capecitabine—esophageal cancer	0.000548	0.00329	CcSEcCtD
Hydromorphone—Respiratory failure—Methotrexate—esophageal cancer	0.000538	0.00323	CcSEcCtD
Hydromorphone—Blood uric acid increased—Methotrexate—esophageal cancer	0.000538	0.00323	CcSEcCtD
Hydromorphone—Lethargy—Capecitabine—esophageal cancer	0.000526	0.00315	CcSEcCtD
Hydromorphone—Stomatitis—Cisplatin—esophageal cancer	0.000525	0.00315	CcSEcCtD
Hydromorphone—Hyponatraemia—Capecitabine—esophageal cancer	0.000517	0.0031	CcSEcCtD
Hydromorphone—Osteoarthritis—Capecitabine—esophageal cancer	0.000515	0.00309	CcSEcCtD
Hydromorphone—Pain in extremity—Capecitabine—esophageal cancer	0.000515	0.00309	CcSEcCtD
Hydromorphone—Diplopia—Capecitabine—esophageal cancer	0.000515	0.00309	CcSEcCtD
Hydromorphone—Disturbance in sexual arousal—Capecitabine—esophageal cancer	0.000511	0.00307	CcSEcCtD
Hydromorphone—Depressed level of consciousness—Methotrexate—esophageal cancer	0.00051	0.00306	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Cisplatin—esophageal cancer	0.000509	0.00305	CcSEcCtD
Hydromorphone—Migraine—Capecitabine—esophageal cancer	0.000507	0.00304	CcSEcCtD
Hydromorphone—Naltrexone—ABCB1—esophageal cancer	0.000494	0.111	CrCbGaD
Hydromorphone—Bradycardia—Cisplatin—esophageal cancer	0.000492	0.00295	CcSEcCtD
Hydromorphone—Urinary retention—Capecitabine—esophageal cancer	0.00049	0.00294	CcSEcCtD
Hydromorphone—Cardiac arrest—Capecitabine—esophageal cancer	0.00049	0.00294	CcSEcCtD
Hydromorphone—Mood swings—Capecitabine—esophageal cancer	0.000488	0.00293	CcSEcCtD
Hydromorphone—Coma—Methotrexate—esophageal cancer	0.000483	0.0029	CcSEcCtD
Hydromorphone—Dehydration—Capecitabine—esophageal cancer	0.000479	0.00287	CcSEcCtD
Hydromorphone—Urine output increased—Methotrexate—esophageal cancer	0.000478	0.00286	CcSEcCtD
Hydromorphone—Urinary tract disorder—Cisplatin—esophageal cancer	0.000477	0.00286	CcSEcCtD
Hydromorphone—Connective tissue disorder—Cisplatin—esophageal cancer	0.000475	0.00285	CcSEcCtD
Hydromorphone—Urethral disorder—Cisplatin—esophageal cancer	0.000474	0.00284	CcSEcCtD
Hydromorphone—Orthostatic hypotension—Capecitabine—esophageal cancer	0.000471	0.00282	CcSEcCtD
Hydromorphone—Abdominal pain upper—Capecitabine—esophageal cancer	0.000471	0.00282	CcSEcCtD
Hydromorphone—Pulmonary oedema—Methotrexate—esophageal cancer	0.00047	0.00282	CcSEcCtD
Hydromorphone—Visual impairment—Cisplatin—esophageal cancer	0.000466	0.00279	CcSEcCtD
Hydromorphone—Breast disorder—Capecitabine—esophageal cancer	0.000466	0.00279	CcSEcCtD
Hydromorphone—Aspartate aminotransferase increased—Capecitabine—esophageal cancer	0.000464	0.00278	CcSEcCtD
Hydromorphone—Nasopharyngitis—Capecitabine—esophageal cancer	0.000461	0.00276	CcSEcCtD
Hydromorphone—Gastritis—Capecitabine—esophageal cancer	0.000456	0.00273	CcSEcCtD
Hydromorphone—Muscular weakness—Capecitabine—esophageal cancer	0.000454	0.00272	CcSEcCtD
Hydromorphone—Eye disorder—Cisplatin—esophageal cancer	0.000452	0.00271	CcSEcCtD
Hydromorphone—Tinnitus—Cisplatin—esophageal cancer	0.000451	0.0027	CcSEcCtD
Hydromorphone—Flushing—Cisplatin—esophageal cancer	0.000449	0.00269	CcSEcCtD
Hydromorphone—Cardiac disorder—Cisplatin—esophageal cancer	0.000449	0.00269	CcSEcCtD
Hydromorphone—Abdominal distension—Capecitabine—esophageal cancer	0.000448	0.00269	CcSEcCtD
Hydromorphone—Asthma—Capecitabine—esophageal cancer	0.000445	0.00267	CcSEcCtD
Hydromorphone—Dysphagia—Capecitabine—esophageal cancer	0.000445	0.00267	CcSEcCtD
Hydromorphone—Bronchospasm—Capecitabine—esophageal cancer	0.000438	0.00263	CcSEcCtD
Hydromorphone—Polyuria—Methotrexate—esophageal cancer	0.000437	0.00262	CcSEcCtD
Hydromorphone—Immune system disorder—Cisplatin—esophageal cancer	0.000437	0.00262	CcSEcCtD
Hydromorphone—Mediastinal disorder—Cisplatin—esophageal cancer	0.000436	0.00261	CcSEcCtD
Hydromorphone—Sweating increased—Capecitabine—esophageal cancer	0.000434	0.0026	CcSEcCtD
Hydromorphone—Arrhythmia—Cisplatin—esophageal cancer	0.000432	0.00259	CcSEcCtD
Hydromorphone—Erythema—Cisplatin—esophageal cancer	0.000421	0.00252	CcSEcCtD
Hydromorphone—Malnutrition—Cisplatin—esophageal cancer	0.000421	0.00252	CcSEcCtD
Hydromorphone—Dysuria—Capecitabine—esophageal cancer	0.000416	0.0025	CcSEcCtD
Hydromorphone—Flatulence—Cisplatin—esophageal cancer	0.000415	0.00249	CcSEcCtD
Hydromorphone—Visual disturbance—Methotrexate—esophageal cancer	0.000405	0.00243	CcSEcCtD
Hydromorphone—Muscle spasms—Cisplatin—esophageal cancer	0.000405	0.00243	CcSEcCtD
Hydromorphone—Weight decreased—Capecitabine—esophageal cancer	0.000403	0.00242	CcSEcCtD
Hydromorphone—Infestation NOS—Capecitabine—esophageal cancer	0.000397	0.00238	CcSEcCtD
Hydromorphone—Infestation—Capecitabine—esophageal cancer	0.000397	0.00238	CcSEcCtD
Hydromorphone—Vision blurred—Cisplatin—esophageal cancer	0.000397	0.00238	CcSEcCtD
Hydromorphone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000396	0.00238	CcSEcCtD
Hydromorphone—Depression—Capecitabine—esophageal cancer	0.000396	0.00237	CcSEcCtD
Hydromorphone—Tremor—Cisplatin—esophageal cancer	0.000394	0.00236	CcSEcCtD
Hydromorphone—Lethargy—Methotrexate—esophageal cancer	0.000391	0.00235	CcSEcCtD
Hydromorphone—Ill-defined disorder—Cisplatin—esophageal cancer	0.00039	0.00234	CcSEcCtD
Hydromorphone—Stomatitis—Capecitabine—esophageal cancer	0.000387	0.00232	CcSEcCtD
Hydromorphone—Osteoarthritis—Methotrexate—esophageal cancer	0.000383	0.0023	CcSEcCtD
Hydromorphone—Malaise—Cisplatin—esophageal cancer	0.00038	0.00228	CcSEcCtD
Hydromorphone—Leukopenia—Cisplatin—esophageal cancer	0.000377	0.00226	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Capecitabine—esophageal cancer	0.000375	0.00225	CcSEcCtD
Hydromorphone—Convulsion—Cisplatin—esophageal cancer	0.000365	0.00219	CcSEcCtD
Hydromorphone—Mood swings—Methotrexate—esophageal cancer	0.000363	0.00218	CcSEcCtD
Hydromorphone—Bradycardia—Capecitabine—esophageal cancer	0.000363	0.00218	CcSEcCtD
Hydromorphone—Naloxone—ABCB1—esophageal cancer	0.000361	0.0812	CrCbGaD
Hydromorphone—Myalgia—Cisplatin—esophageal cancer	0.000358	0.00215	CcSEcCtD
Hydromorphone—Rhinitis—Capecitabine—esophageal cancer	0.000357	0.00214	CcSEcCtD
Hydromorphone—Anxiety—Cisplatin—esophageal cancer	0.000357	0.00214	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000356	0.00213	CcSEcCtD
Hydromorphone—Hypoaesthesia—Capecitabine—esophageal cancer	0.000355	0.00213	CcSEcCtD
Hydromorphone—Discomfort—Cisplatin—esophageal cancer	0.000354	0.00212	CcSEcCtD
Hydromorphone—Urinary tract disorder—Capecitabine—esophageal cancer	0.000352	0.00211	CcSEcCtD
Hydromorphone—Oedema peripheral—Capecitabine—esophageal cancer	0.000351	0.00211	CcSEcCtD
Hydromorphone—Connective tissue disorder—Capecitabine—esophageal cancer	0.00035	0.0021	CcSEcCtD
Hydromorphone—Urethral disorder—Capecitabine—esophageal cancer	0.000349	0.0021	CcSEcCtD
Hydromorphone—Breast disorder—Methotrexate—esophageal cancer	0.000347	0.00208	CcSEcCtD
Hydromorphone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000343	0.00206	CcSEcCtD
Hydromorphone—Visual impairment—Capecitabine—esophageal cancer	0.000343	0.00206	CcSEcCtD
Hydromorphone—Infection—Cisplatin—esophageal cancer	0.000341	0.00205	CcSEcCtD
Hydromorphone—Nervous system disorder—Cisplatin—esophageal cancer	0.000337	0.00202	CcSEcCtD
Hydromorphone—Tachycardia—Cisplatin—esophageal cancer	0.000335	0.00201	CcSEcCtD
Hydromorphone—Skin disorder—Cisplatin—esophageal cancer	0.000334	0.002	CcSEcCtD
Hydromorphone—Eye disorder—Capecitabine—esophageal cancer	0.000333	0.002	CcSEcCtD
Hydromorphone—Tinnitus—Capecitabine—esophageal cancer	0.000332	0.00199	CcSEcCtD
Hydromorphone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000332	0.00199	CcSEcCtD
Hydromorphone—Asthma—Methotrexate—esophageal cancer	0.000331	0.00199	CcSEcCtD
Hydromorphone—Flushing—Capecitabine—esophageal cancer	0.000331	0.00198	CcSEcCtD
Hydromorphone—Cardiac disorder—Capecitabine—esophageal cancer	0.000331	0.00198	CcSEcCtD
Hydromorphone—Anorexia—Cisplatin—esophageal cancer	0.000327	0.00196	CcSEcCtD
Hydromorphone—Angiopathy—Capecitabine—esophageal cancer	0.000323	0.00194	CcSEcCtD
Hydromorphone—Immune system disorder—Capecitabine—esophageal cancer	0.000322	0.00193	CcSEcCtD
Hydromorphone—Mediastinal disorder—Capecitabine—esophageal cancer	0.000321	0.00193	CcSEcCtD
Hydromorphone—Hypotension—Cisplatin—esophageal cancer	0.000321	0.00192	CcSEcCtD
Hydromorphone—Chills—Capecitabine—esophageal cancer	0.00032	0.00192	CcSEcCtD
Hydromorphone—Arrhythmia—Capecitabine—esophageal cancer	0.000318	0.00191	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000313	0.00188	CcSEcCtD
Hydromorphone—Mental disorder—Capecitabine—esophageal cancer	0.000312	0.00187	CcSEcCtD
Hydromorphone—Malnutrition—Capecitabine—esophageal cancer	0.00031	0.00186	CcSEcCtD
Hydromorphone—Erythema—Capecitabine—esophageal cancer	0.00031	0.00186	CcSEcCtD
Hydromorphone—Dysuria—Methotrexate—esophageal cancer	0.00031	0.00186	CcSEcCtD
Hydromorphone—Paraesthesia—Cisplatin—esophageal cancer	0.000308	0.00185	CcSEcCtD
Hydromorphone—Dyspnoea—Cisplatin—esophageal cancer	0.000306	0.00184	CcSEcCtD
Hydromorphone—Flatulence—Capecitabine—esophageal cancer	0.000306	0.00183	CcSEcCtD
Hydromorphone—Erectile dysfunction—Methotrexate—esophageal cancer	0.000305	0.00183	CcSEcCtD
Hydromorphone—Morphine—ABCB1—esophageal cancer	0.000304	0.0686	CrCbGaD
Hydromorphone—Dysgeusia—Capecitabine—esophageal cancer	0.000304	0.00182	CcSEcCtD
Hydromorphone—Back pain—Capecitabine—esophageal cancer	0.0003	0.0018	CcSEcCtD
Hydromorphone—Decreased appetite—Cisplatin—esophageal cancer	0.000299	0.00179	CcSEcCtD
Hydromorphone—Muscle spasms—Capecitabine—esophageal cancer	0.000298	0.00179	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000297	0.00178	CcSEcCtD
Hydromorphone—Infestation NOS—Methotrexate—esophageal cancer	0.000296	0.00177	CcSEcCtD
Hydromorphone—Drowsiness—Methotrexate—esophageal cancer	0.000296	0.00177	CcSEcCtD
Hydromorphone—Infestation—Methotrexate—esophageal cancer	0.000296	0.00177	CcSEcCtD
Hydromorphone—Depression—Methotrexate—esophageal cancer	0.000295	0.00177	CcSEcCtD
Hydromorphone—Pain—Cisplatin—esophageal cancer	0.000294	0.00176	CcSEcCtD
Hydromorphone—Vision blurred—Capecitabine—esophageal cancer	0.000292	0.00175	CcSEcCtD
Hydromorphone—Tremor—Capecitabine—esophageal cancer	0.000291	0.00174	CcSEcCtD
Hydromorphone—Stomatitis—Methotrexate—esophageal cancer	0.000288	0.00173	CcSEcCtD
Hydromorphone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000288	0.00173	CcSEcCtD
Hydromorphone—Sweating—Methotrexate—esophageal cancer	0.000283	0.0017	CcSEcCtD
Hydromorphone—Feeling abnormal—Cisplatin—esophageal cancer	0.000283	0.0017	CcSEcCtD
Hydromorphone—Malaise—Capecitabine—esophageal cancer	0.00028	0.00168	CcSEcCtD
Hydromorphone—Hepatobiliary disease—Methotrexate—esophageal cancer	0.000279	0.00168	CcSEcCtD
Hydromorphone—Vertigo—Capecitabine—esophageal cancer	0.000279	0.00167	CcSEcCtD
Hydromorphone—Syncope—Capecitabine—esophageal cancer	0.000278	0.00167	CcSEcCtD
Hydromorphone—Leukopenia—Capecitabine—esophageal cancer	0.000278	0.00167	CcSEcCtD
Hydromorphone—Palpitations—Capecitabine—esophageal cancer	0.000274	0.00164	CcSEcCtD
Hydromorphone—Loss of consciousness—Capecitabine—esophageal cancer	0.000273	0.00164	CcSEcCtD
Hydromorphone—Body temperature increased—Cisplatin—esophageal cancer	0.000272	0.00163	CcSEcCtD
Hydromorphone—Cough—Capecitabine—esophageal cancer	0.000271	0.00162	CcSEcCtD
Hydromorphone—Hypertension—Capecitabine—esophageal cancer	0.000268	0.00161	CcSEcCtD
Hydromorphone—Arthralgia—Capecitabine—esophageal cancer	0.000264	0.00158	CcSEcCtD
Hydromorphone—Myalgia—Capecitabine—esophageal cancer	0.000264	0.00158	CcSEcCtD
Hydromorphone—Chest pain—Capecitabine—esophageal cancer	0.000264	0.00158	CcSEcCtD
Hydromorphone—Anxiety—Capecitabine—esophageal cancer	0.000263	0.00158	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000262	0.00157	CcSEcCtD
Hydromorphone—Urinary tract disorder—Methotrexate—esophageal cancer	0.000262	0.00157	CcSEcCtD
Hydromorphone—Discomfort—Capecitabine—esophageal cancer	0.000261	0.00157	CcSEcCtD
Hydromorphone—Urethral disorder—Methotrexate—esophageal cancer	0.00026	0.00156	CcSEcCtD
Hydromorphone—Dry mouth—Capecitabine—esophageal cancer	0.000258	0.00155	CcSEcCtD
Hydromorphone—Dextromethorphan—ABCB1—esophageal cancer	0.000256	0.0576	CrCbGaD
Hydromorphone—Visual impairment—Methotrexate—esophageal cancer	0.000256	0.00153	CcSEcCtD
Hydromorphone—Confusional state—Capecitabine—esophageal cancer	0.000255	0.00153	CcSEcCtD
Hydromorphone—Hypersensitivity—Cisplatin—esophageal cancer	0.000253	0.00152	CcSEcCtD
Hydromorphone—Infection—Capecitabine—esophageal cancer	0.000252	0.00151	CcSEcCtD
Hydromorphone—Shock—Capecitabine—esophageal cancer	0.000249	0.00149	CcSEcCtD
Hydromorphone—Nervous system disorder—Capecitabine—esophageal cancer	0.000248	0.00149	CcSEcCtD
Hydromorphone—Eye disorder—Methotrexate—esophageal cancer	0.000248	0.00149	CcSEcCtD
Hydromorphone—Tinnitus—Methotrexate—esophageal cancer	0.000247	0.00148	CcSEcCtD
Hydromorphone—Tachycardia—Capecitabine—esophageal cancer	0.000247	0.00148	CcSEcCtD
Hydromorphone—Asthenia—Cisplatin—esophageal cancer	0.000246	0.00148	CcSEcCtD
Hydromorphone—Cardiac disorder—Methotrexate—esophageal cancer	0.000246	0.00148	CcSEcCtD
Hydromorphone—Skin disorder—Capecitabine—esophageal cancer	0.000246	0.00148	CcSEcCtD
Hydromorphone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000245	0.00147	CcSEcCtD
Hydromorphone—Anorexia—Capecitabine—esophageal cancer	0.000241	0.00145	CcSEcCtD
Hydromorphone—Angiopathy—Methotrexate—esophageal cancer	0.000241	0.00144	CcSEcCtD
Hydromorphone—Immune system disorder—Methotrexate—esophageal cancer	0.00024	0.00144	CcSEcCtD
Hydromorphone—Mediastinal disorder—Methotrexate—esophageal cancer	0.000239	0.00143	CcSEcCtD
Hydromorphone—Chills—Methotrexate—esophageal cancer	0.000238	0.00143	CcSEcCtD
Hydromorphone—Hypotension—Capecitabine—esophageal cancer	0.000237	0.00142	CcSEcCtD
Hydromorphone—Diarrhoea—Cisplatin—esophageal cancer	0.000235	0.00141	CcSEcCtD
Hydromorphone—Mental disorder—Methotrexate—esophageal cancer	0.000232	0.00139	CcSEcCtD
Hydromorphone—Erythema—Methotrexate—esophageal cancer	0.000231	0.00139	CcSEcCtD
Hydromorphone—Malnutrition—Methotrexate—esophageal cancer	0.000231	0.00139	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000231	0.00138	CcSEcCtD
Hydromorphone—Insomnia—Capecitabine—esophageal cancer	0.000229	0.00137	CcSEcCtD
Hydromorphone—Paraesthesia—Capecitabine—esophageal cancer	0.000227	0.00136	CcSEcCtD
Hydromorphone—Dysgeusia—Methotrexate—esophageal cancer	0.000226	0.00136	CcSEcCtD
Hydromorphone—Dyspnoea—Capecitabine—esophageal cancer	0.000226	0.00135	CcSEcCtD
Hydromorphone—Back pain—Methotrexate—esophageal cancer	0.000223	0.00134	CcSEcCtD
Hydromorphone—Dyspepsia—Capecitabine—esophageal cancer	0.000223	0.00134	CcSEcCtD
Hydromorphone—Decreased appetite—Capecitabine—esophageal cancer	0.00022	0.00132	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000219	0.00131	CcSEcCtD
Hydromorphone—Vomiting—Cisplatin—esophageal cancer	0.000218	0.00131	CcSEcCtD
Hydromorphone—Fatigue—Capecitabine—esophageal cancer	0.000218	0.00131	CcSEcCtD
Hydromorphone—Vision blurred—Methotrexate—esophageal cancer	0.000218	0.00131	CcSEcCtD
Hydromorphone—Rash—Cisplatin—esophageal cancer	0.000217	0.0013	CcSEcCtD
Hydromorphone—Pain—Capecitabine—esophageal cancer	0.000217	0.0013	CcSEcCtD
Hydromorphone—Constipation—Capecitabine—esophageal cancer	0.000217	0.0013	CcSEcCtD
Hydromorphone—Dermatitis—Cisplatin—esophageal cancer	0.000216	0.0013	CcSEcCtD
Hydromorphone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000214	0.00129	CcSEcCtD
Hydromorphone—Feeling abnormal—Capecitabine—esophageal cancer	0.000209	0.00125	CcSEcCtD
Hydromorphone—Malaise—Methotrexate—esophageal cancer	0.000208	0.00125	CcSEcCtD
Hydromorphone—Vertigo—Methotrexate—esophageal cancer	0.000207	0.00124	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000207	0.00124	CcSEcCtD
Hydromorphone—Leukopenia—Methotrexate—esophageal cancer	0.000207	0.00124	CcSEcCtD
Hydromorphone—Nausea—Cisplatin—esophageal cancer	0.000204	0.00122	CcSEcCtD
Hydromorphone—Cough—Methotrexate—esophageal cancer	0.000202	0.00121	CcSEcCtD
Hydromorphone—Urticaria—Capecitabine—esophageal cancer	0.000201	0.00121	CcSEcCtD
Hydromorphone—Abdominal pain—Capecitabine—esophageal cancer	0.0002	0.0012	CcSEcCtD
Hydromorphone—Body temperature increased—Capecitabine—esophageal cancer	0.0002	0.0012	CcSEcCtD
Hydromorphone—Convulsion—Methotrexate—esophageal cancer	0.0002	0.0012	CcSEcCtD
Hydromorphone—Chest pain—Methotrexate—esophageal cancer	0.000197	0.00118	CcSEcCtD
Hydromorphone—Myalgia—Methotrexate—esophageal cancer	0.000197	0.00118	CcSEcCtD
Hydromorphone—Arthralgia—Methotrexate—esophageal cancer	0.000197	0.00118	CcSEcCtD
Hydromorphone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.000195	0.00117	CcSEcCtD
Hydromorphone—Discomfort—Methotrexate—esophageal cancer	0.000194	0.00117	CcSEcCtD
Hydromorphone—Confusional state—Methotrexate—esophageal cancer	0.00019	0.00114	CcSEcCtD
Hydromorphone—Anaphylactic shock—Methotrexate—esophageal cancer	0.000188	0.00113	CcSEcCtD
Hydromorphone—Infection—Methotrexate—esophageal cancer	0.000187	0.00112	CcSEcCtD
Hydromorphone—Hypersensitivity—Capecitabine—esophageal cancer	0.000187	0.00112	CcSEcCtD
Hydromorphone—Nervous system disorder—Methotrexate—esophageal cancer	0.000185	0.00111	CcSEcCtD
Hydromorphone—Skin disorder—Methotrexate—esophageal cancer	0.000183	0.0011	CcSEcCtD
Hydromorphone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000182	0.00109	CcSEcCtD
Hydromorphone—Asthenia—Capecitabine—esophageal cancer	0.000182	0.00109	CcSEcCtD
Hydromorphone—Anorexia—Methotrexate—esophageal cancer	0.00018	0.00108	CcSEcCtD
Hydromorphone—Pruritus—Capecitabine—esophageal cancer	0.000179	0.00107	CcSEcCtD
Hydromorphone—Hypotension—Methotrexate—esophageal cancer	0.000176	0.00106	CcSEcCtD
Hydromorphone—Diarrhoea—Capecitabine—esophageal cancer	0.000173	0.00104	CcSEcCtD
Hydromorphone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000172	0.00103	CcSEcCtD
Hydromorphone—Insomnia—Methotrexate—esophageal cancer	0.00017	0.00102	CcSEcCtD
Hydromorphone—Paraesthesia—Methotrexate—esophageal cancer	0.000169	0.00102	CcSEcCtD
Hydromorphone—Dyspnoea—Methotrexate—esophageal cancer	0.000168	0.00101	CcSEcCtD
Hydromorphone—Somnolence—Methotrexate—esophageal cancer	0.000168	0.001	CcSEcCtD
Hydromorphone—Dizziness—Capecitabine—esophageal cancer	0.000167	0.001	CcSEcCtD
Hydromorphone—Dyspepsia—Methotrexate—esophageal cancer	0.000166	0.000995	CcSEcCtD
Hydromorphone—Decreased appetite—Methotrexate—esophageal cancer	0.000164	0.000983	CcSEcCtD
Hydromorphone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000163	0.000976	CcSEcCtD
Hydromorphone—Fatigue—Methotrexate—esophageal cancer	0.000163	0.000975	CcSEcCtD
Hydromorphone—Pain—Methotrexate—esophageal cancer	0.000161	0.000967	CcSEcCtD
Hydromorphone—Vomiting—Capecitabine—esophageal cancer	0.000161	0.000966	CcSEcCtD
Hydromorphone—Rash—Capecitabine—esophageal cancer	0.00016	0.000957	CcSEcCtD
Hydromorphone—Dermatitis—Capecitabine—esophageal cancer	0.000159	0.000957	CcSEcCtD
Hydromorphone—Headache—Capecitabine—esophageal cancer	0.000159	0.000951	CcSEcCtD
Hydromorphone—Feeling abnormal—Methotrexate—esophageal cancer	0.000155	0.000932	CcSEcCtD
Hydromorphone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000154	0.000924	CcSEcCtD
Hydromorphone—Nausea—Capecitabine—esophageal cancer	0.00015	0.000902	CcSEcCtD
Hydromorphone—Urticaria—Methotrexate—esophageal cancer	0.00015	0.000898	CcSEcCtD
Hydromorphone—Abdominal pain—Methotrexate—esophageal cancer	0.000149	0.000894	CcSEcCtD
Hydromorphone—Body temperature increased—Methotrexate—esophageal cancer	0.000149	0.000894	CcSEcCtD
Hydromorphone—Hypersensitivity—Methotrexate—esophageal cancer	0.000139	0.000833	CcSEcCtD
Hydromorphone—Asthenia—Methotrexate—esophageal cancer	0.000135	0.000811	CcSEcCtD
Hydromorphone—Pruritus—Methotrexate—esophageal cancer	0.000133	0.0008	CcSEcCtD
Hydromorphone—Diarrhoea—Methotrexate—esophageal cancer	0.000129	0.000773	CcSEcCtD
Hydromorphone—Dizziness—Methotrexate—esophageal cancer	0.000125	0.000748	CcSEcCtD
Hydromorphone—Vomiting—Methotrexate—esophageal cancer	0.00012	0.000719	CcSEcCtD
Hydromorphone—Rash—Methotrexate—esophageal cancer	0.000119	0.000713	CcSEcCtD
Hydromorphone—Dermatitis—Methotrexate—esophageal cancer	0.000119	0.000712	CcSEcCtD
Hydromorphone—Headache—Methotrexate—esophageal cancer	0.000118	0.000708	CcSEcCtD
Hydromorphone—Nausea—Methotrexate—esophageal cancer	0.000112	0.000671	CcSEcCtD
Hydromorphone—OPRD1—Signaling Pathways—XIAP—esophageal cancer	5.13e-05	0.000443	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HIST1H2BM—esophageal cancer	5.1e-05	0.000439	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PDE4D—esophageal cancer	5.05e-05	0.000436	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	5.02e-05	0.000433	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP26A1—esophageal cancer	5.01e-05	0.000432	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GNG7—esophageal cancer	4.97e-05	0.000428	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALOX15—esophageal cancer	4.88e-05	0.000421	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CTNNA1—esophageal cancer	4.86e-05	0.000419	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CXCL2—esophageal cancer	4.83e-05	0.000416	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GNG7—esophageal cancer	4.8e-05	0.000414	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ELMO1—esophageal cancer	4.78e-05	0.000412	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—AKAP13—esophageal cancer	4.67e-05	0.000402	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ALDH2—esophageal cancer	4.65e-05	0.000401	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—TPI1—esophageal cancer	4.65e-05	0.000401	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTO1—esophageal cancer	4.65e-05	0.000401	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PSME2—esophageal cancer	4.51e-05	0.000389	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PSME1—esophageal cancer	4.51e-05	0.000389	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC52A3—esophageal cancer	4.5e-05	0.000388	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—BLVRB—esophageal cancer	4.5e-05	0.000388	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—XIAP—esophageal cancer	4.5e-05	0.000388	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ANXA1—esophageal cancer	4.49e-05	0.000387	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—BLVRB—esophageal cancer	4.46e-05	0.000385	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC52A3—esophageal cancer	4.46e-05	0.000385	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALDOB—esophageal cancer	4.46e-05	0.000385	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—GSTT1—esophageal cancer	4.43e-05	0.000382	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP2A6—esophageal cancer	4.38e-05	0.000377	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SST—esophageal cancer	4.37e-05	0.000376	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	4.36e-05	0.000376	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HIST1H2BM—esophageal cancer	4.31e-05	0.000371	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GAPDH—esophageal cancer	4.29e-05	0.00037	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PDE4D—esophageal cancer	4.27e-05	0.000368	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CTNNA1—esophageal cancer	4.26e-05	0.000367	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CRABP1—esophageal cancer	4.26e-05	0.000367	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—GHRL—esophageal cancer	4.25e-05	0.000367	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOTCH3—esophageal cancer	4.25e-05	0.000367	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CXCL2—esophageal cancer	4.23e-05	0.000365	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—FBXW7—esophageal cancer	4.19e-05	0.000361	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ENO1—esophageal cancer	4.15e-05	0.000358	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS1—esophageal cancer	4.15e-05	0.000358	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PSME1—esophageal cancer	4.09e-05	0.000352	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PSME2—esophageal cancer	4.09e-05	0.000352	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GNG7—esophageal cancer	4.06e-05	0.00035	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GNG7—esophageal cancer	4.05e-05	0.000349	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	3.99e-05	0.000344	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PSME1—esophageal cancer	3.95e-05	0.000341	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PSME2—esophageal cancer	3.95e-05	0.000341	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ANXA1—esophageal cancer	3.94e-05	0.000339	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	3.83e-05	0.00033	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CA1—esophageal cancer	3.83e-05	0.00033	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SST—esophageal cancer	3.83e-05	0.00033	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOTCH2—esophageal cancer	3.82e-05	0.000329	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—XIAP—esophageal cancer	3.8e-05	0.000328	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—SLC10A2—esophageal cancer	3.8e-05	0.000327	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CA1—esophageal cancer	3.8e-05	0.000327	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ALDH2—esophageal cancer	3.79e-05	0.000327	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—GHRL—esophageal cancer	3.73e-05	0.000322	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOTCH3—esophageal cancer	3.73e-05	0.000322	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—FBXW7—esophageal cancer	3.67e-05	0.000316	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—GSTT1—esophageal cancer	3.61e-05	0.000311	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CTNNA1—esophageal cancer	3.6e-05	0.00031	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CXCL2—esophageal cancer	3.58e-05	0.000308	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	3.57e-05	0.000308	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP2A6—esophageal cancer	3.57e-05	0.000308	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.55e-05	0.000306	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP1B1—esophageal cancer	3.53e-05	0.000304	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CA2—esophageal cancer	3.5e-05	0.000302	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CA2—esophageal cancer	3.47e-05	0.000299	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	3.39e-05	0.000293	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TGFBR2—esophageal cancer	3.39e-05	0.000292	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ENO1—esophageal cancer	3.38e-05	0.000292	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOTCH2—esophageal cancer	3.35e-05	0.000289	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PSME1—esophageal cancer	3.34e-05	0.000288	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PSME2—esophageal cancer	3.34e-05	0.000288	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PSME1—esophageal cancer	3.33e-05	0.000287	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PSME2—esophageal cancer	3.33e-05	0.000287	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ANXA1—esophageal cancer	3.33e-05	0.000287	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CYP19A1—esophageal cancer	3.32e-05	0.000286	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ADH7—esophageal cancer	3.26e-05	0.000281	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PLCE1—esophageal cancer	3.26e-05	0.000281	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SST—esophageal cancer	3.24e-05	0.000279	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PLCE1—esophageal cancer	3.23e-05	0.000278	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ADH7—esophageal cancer	3.23e-05	0.000278	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—SMAD4—esophageal cancer	3.2e-05	0.000276	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	3.19e-05	0.000275	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—GHRL—esophageal cancer	3.15e-05	0.000272	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOTCH3—esophageal cancer	3.15e-05	0.000272	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—FBXW7—esophageal cancer	3.1e-05	0.000267	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—HMOX1—esophageal cancer	3.03e-05	0.000261	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.97e-05	0.000256	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TGFBR2—esophageal cancer	2.97e-05	0.000256	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.94e-05	0.000254	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.94e-05	0.000254	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.91e-05	0.000251	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—ABCB1—esophageal cancer	2.9e-05	0.00025	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP1B1—esophageal cancer	2.87e-05	0.000248	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ADH1B—esophageal cancer	2.86e-05	0.000246	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ADH1B—esophageal cancer	2.83e-05	0.000244	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOTCH2—esophageal cancer	2.83e-05	0.000244	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—SMAD4—esophageal cancer	2.81e-05	0.000242	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TYMP—esophageal cancer	2.73e-05	0.000235	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TYMP—esophageal cancer	2.71e-05	0.000233	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CYP19A1—esophageal cancer	2.7e-05	0.000233	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	2.65e-05	0.000229	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP26A1—esophageal cancer	2.63e-05	0.000227	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—HIF1A—esophageal cancer	2.62e-05	0.000226	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALOX15—esophageal cancer	2.59e-05	0.000223	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALOX15—esophageal cancer	2.56e-05	0.000221	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TGFBR2—esophageal cancer	2.51e-05	0.000216	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—KDR—esophageal cancer	2.51e-05	0.000216	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	2.5e-05	0.000216	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CA1—esophageal cancer	2.5e-05	0.000216	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTO1—esophageal cancer	2.47e-05	0.000213	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—TPI1—esophageal cancer	2.47e-05	0.000213	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—HMOX1—esophageal cancer	2.47e-05	0.000213	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—TPI1—esophageal cancer	2.45e-05	0.000211	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTO1—esophageal cancer	2.45e-05	0.000211	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.42e-05	0.000209	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—SMAD4—esophageal cancer	2.37e-05	0.000205	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—ABCB1—esophageal cancer	2.37e-05	0.000204	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALDOB—esophageal cancer	2.37e-05	0.000204	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOTCH1—esophageal cancer	2.36e-05	0.000204	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALDOB—esophageal cancer	2.35e-05	0.000202	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—HIF1A—esophageal cancer	2.3e-05	0.000198	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CA2—esophageal cancer	2.29e-05	0.000197	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GAPDH—esophageal cancer	2.28e-05	0.000196	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GAPDH—esophageal cancer	2.26e-05	0.000195	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CRABP1—esophageal cancer	2.26e-05	0.000195	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CRABP1—esophageal cancer	2.24e-05	0.000193	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—KDR—esophageal cancer	2.2e-05	0.00019	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	2.2e-05	0.000189	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GNG7—esophageal cancer	2.15e-05	0.000185	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CREBBP—esophageal cancer	2.14e-05	0.000185	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PLCE1—esophageal cancer	2.13e-05	0.000184	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ADH7—esophageal cancer	2.13e-05	0.000184	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GNG7—esophageal cancer	2.13e-05	0.000184	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—EGFR—esophageal cancer	2.1e-05	0.000181	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOTCH1—esophageal cancer	2.07e-05	0.000179	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ALDH2—esophageal cancer	2.01e-05	0.000173	CbGpPWpGaD
Hydromorphone—OPRD1—GPCR downstream signaling—PIK3CA—esophageal cancer	2.01e-05	0.000173	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ALDH2—esophageal cancer	1.99e-05	0.000172	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—HIF1A—esophageal cancer	1.94e-05	0.000168	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—CREBBP—esophageal cancer	1.94e-05	0.000167	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—NOS3—esophageal cancer	1.92e-05	0.000165	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—GSTT1—esophageal cancer	1.91e-05	0.000165	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—GSTT1—esophageal cancer	1.9e-05	0.000164	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	1.89e-05	0.000163	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CREBBP—esophageal cancer	1.88e-05	0.000162	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP2A6—esophageal cancer	1.87e-05	0.000162	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	1.87e-05	0.000161	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.87e-05	0.000161	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—KDR—esophageal cancer	1.86e-05	0.00016	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—EGFR—esophageal cancer	1.85e-05	0.000159	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling by GPCR—PIK3CA—esophageal cancer	1.83e-05	0.000157	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—ERBB2—esophageal cancer	1.79e-05	0.000155	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS1—esophageal cancer	1.79e-05	0.000155	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ENO1—esophageal cancer	1.79e-05	0.000155	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.79e-05	0.000154	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TYMP—esophageal cancer	1.78e-05	0.000154	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ENO1—esophageal cancer	1.78e-05	0.000153	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS1—esophageal cancer	1.78e-05	0.000153	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSME1—esophageal cancer	1.77e-05	0.000152	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PSME2—esophageal cancer	1.77e-05	0.000152	CbGpPWpGaD
Hydromorphone—OPRK1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.76e-05	0.000152	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSME2—esophageal cancer	1.75e-05	0.000151	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PSME1—esophageal cancer	1.75e-05	0.000151	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOTCH1—esophageal cancer	1.75e-05	0.000151	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—NOS3—esophageal cancer	1.74e-05	0.00015	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.74e-05	0.00015	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.69e-05	0.000146	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—NOS3—esophageal cancer	1.68e-05	0.000145	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.61e-05	0.000139	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—TPI1—esophageal cancer	1.61e-05	0.000139	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling by GPCR—PIK3CA—esophageal cancer	1.6e-05	0.000138	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PTGS2—esophageal cancer	1.59e-05	0.000137	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CREBBP—esophageal cancer	1.59e-05	0.000137	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CCND1—esophageal cancer	1.58e-05	0.000137	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—CREBBP—esophageal cancer	1.58e-05	0.000136	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—ERBB2—esophageal cancer	1.57e-05	0.000136	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—EGFR—esophageal cancer	1.56e-05	0.000134	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.55e-05	0.000133	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—CDKN1A—esophageal cancer	1.53e-05	0.000132	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	1.53e-05	0.000132	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	1.52e-05	0.000131	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP1B1—esophageal cancer	1.51e-05	0.00013	CbGpPWpGaD
Hydromorphone—OPRM1—GPCR downstream signaling—PIK3CA—esophageal cancer	1.49e-05	0.000129	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.49e-05	0.000128	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.48e-05	0.000127	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EP300—esophageal cancer	1.46e-05	0.000126	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	1.43e-05	0.000124	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CYP19A1—esophageal cancer	1.42e-05	0.000123	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—NOS3—esophageal cancer	1.42e-05	0.000123	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—NOS3—esophageal cancer	1.42e-05	0.000122	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GNG7—esophageal cancer	1.4e-05	0.000121	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CCND1—esophageal cancer	1.39e-05	0.00012	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling by GPCR—PIK3CA—esophageal cancer	1.35e-05	0.000117	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—CDKN1A—esophageal cancer	1.34e-05	0.000116	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—ERBB2—esophageal cancer	1.33e-05	0.000115	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—EP300—esophageal cancer	1.32e-05	0.000114	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.32e-05	0.000113	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—HMOX1—esophageal cancer	1.31e-05	0.000113	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—HMOX1—esophageal cancer	1.3e-05	0.000112	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PTGS2—esophageal cancer	1.3e-05	0.000112	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EP300—esophageal cancer	1.28e-05	0.00011	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	1.27e-05	0.00011	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—MYC—esophageal cancer	1.27e-05	0.00011	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.26e-05	0.000108	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.25e-05	0.000108	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—ABCB1—esophageal cancer	1.24e-05	0.000107	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—EGFR—esophageal cancer	1.24e-05	0.000107	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.24e-05	0.000107	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CCND1—esophageal cancer	1.17e-05	0.000101	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ENO1—esophageal cancer	1.17e-05	0.000101	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.17e-05	0.000101	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSME2—esophageal cancer	1.16e-05	9.96e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PSME1—esophageal cancer	1.16e-05	9.96e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—CDKN1A—esophageal cancer	1.14e-05	9.79e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—MYC—esophageal cancer	1.11e-05	9.61e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—EGFR—esophageal cancer	1.09e-05	9.4e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EP300—esophageal cancer	1.08e-05	9.32e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—PIK3CA—esophageal cancer	1.08e-05	9.3e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—EP300—esophageal cancer	1.08e-05	9.29e-05	CbGpPWpGaD
Hydromorphone—OPRD1—Signaling Pathways—TP53—esophageal cancer	1.04e-05	9e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	9.97e-06	8.59e-05	CbGpPWpGaD
Hydromorphone—UGT1A9—Metabolism—PIK3CA—esophageal cancer	9.78e-06	8.43e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—PIK3CA—esophageal cancer	9.46e-06	8.16e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—MYC—esophageal cancer	9.42e-06	8.12e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	9.41e-06	8.11e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	9.37e-06	8.08e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—EGFR—esophageal cancer	9.21e-06	7.94e-05	CbGpPWpGaD
Hydromorphone—OPRK1—Signaling Pathways—TP53—esophageal cancer	9.15e-06	7.89e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—HMOX1—esophageal cancer	8.55e-06	7.37e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—CREBBP—esophageal cancer	8.39e-06	7.23e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—CREBBP—esophageal cancer	8.32e-06	7.17e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—ABCB1—esophageal cancer	8.21e-06	7.08e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—PIK3CA—esophageal cancer	8e-06	6.89e-05	CbGpPWpGaD
Hydromorphone—PTGS1—Metabolism—PIK3CA—esophageal cancer	7.97e-06	6.87e-05	CbGpPWpGaD
Hydromorphone—OPRM1—Signaling Pathways—TP53—esophageal cancer	7.74e-06	6.67e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—NOS3—esophageal cancer	7.51e-06	6.48e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—NOS3—esophageal cancer	7.45e-06	6.42e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PTGS2—esophageal cancer	6.87e-06	5.92e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PTGS2—esophageal cancer	6.81e-06	5.87e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—EP300—esophageal cancer	5.71e-06	4.93e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—EP300—esophageal cancer	5.67e-06	4.88e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—CREBBP—esophageal cancer	5.49e-06	4.73e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—NOS3—esophageal cancer	4.91e-06	4.24e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PTGS2—esophageal cancer	4.49e-06	3.87e-05	CbGpPWpGaD
Hydromorphone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	4.23e-06	3.64e-05	CbGpPWpGaD
Hydromorphone—CYP2C9—Metabolism—PIK3CA—esophageal cancer	4.19e-06	3.61e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—EP300—esophageal cancer	3.74e-06	3.22e-05	CbGpPWpGaD
Hydromorphone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.76e-06	2.38e-05	CbGpPWpGaD
